04.11.25 -- Sourcing Plasmid DNA From CDMOs Got More Challenging — Here's Why

Discover best practices for cryopreserving small-volume ATMPs, focusing on sterility, viability, and efficiency with advanced containers and packaging.

The study investigates the potential of using smartphones and wearables to create objective biomarkers for mood disorders, specifically focusing on unipolar depression.

Hepatitis B is a major global health challenge with no functional cure. However, emerging therapies and ongoing clinical trials are providing hope that a cure is possible.

Bringing cell and gene therapies to market requires more than scientific breakthroughs; manufacturers must navigate complex patient access challenges to ensure these innovations reach those in need.

What is the curative potential of protein design? Marc Lajoie, CEO at Outpace Bio, discusses how de novo proteins can be used to reprogram immune cells. 

AI and data-driven innovations are transforming dermatology clinical trials by enhancing efficiency, data accuracy, and patient access.

Read on as authors explore accessing real-time clinical trial data for proactive study management, using adverse event data to enhance safety and performance, and tools to improve design.

Explore the critical role of meticulously planning ophthalmic assessments in clinical trials, highlighting their potential risks and complexities.